Full Year 2021 Results

FY 2021 Key Stats
€86.5m
EBITDA
8.5%
Organic GP Growth YoY
17.6%
ROCE 2021
16.2c
Adjusted EPS

Group Highlights

€274.5m
2021 GP

Employees

Partnering with 7 of the top 10 pharma companies

and 7 of the top 10 medical device companies
